Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.14 | 0.3 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.055 | 0.3 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.4 |